Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease

키워드

참고문헌 (241)

1. "Fact sheet on the top 10 leading causes of death in 2019" (2020)[URL]
2. Borén J, "Low-density lipoproteins cause atherosclerotic cardiovascular disease : pathophysiological, genetic, and therapeutic insights : a consensus statement from the European Atherosclerosis Society Consensus Panel", Eur Heart J, 41, pp.2313~2330 (2020)
3. Libby P, "Atherosclerosis. Nat Rev Dis Primer", Nat Rev Dis Primers, 5, pp.56~ (2019)
4. Kumar V, "Robbins basic pathology" (2013), Elsevier Saunders
5. Libby P, "Collagenases and cracks in the plaque", J Clin Invest, 123, pp.3201~3203 (2013)
6. Johnson JL, "Metalloproteinases in atherosclerosis", Eur J Pharmacol, 816, pp.93~106 (2017)
7. Welsh JA, "Minimal information for studies of extracellular vesicles(MISEV2023) : from basic to advanced approaches", J Extracell Vesicles, 13, pp.e12404~ (2024)
8. Couch Y, "A brief history of nearly EV-erything-the rise and rise of extracellular vesicles", J Extracell Vesicles, 10, pp.e12144~ (2021)
9. van Niel G, "Shedding light on the cell biology of extracellular vesicles", Nat Rev Mol Cell Biol, 19, pp.213~228 (2018)
10. Ramirez MI, "Technical challenges of working with extracellular vesicles", Nanoscale, 10, pp.881~906 (2018)
11. van Niel G, "Challenges and directions in studying cell-cell communication by extracellular vesicles", Nat Rev Mol Cell Biol, 23, pp.369~382 (2022)
12. Théry C, "Minimal information for studies of extracellular vesicles 2018(MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines", J Extracell Vesicles, 7, pp.1535750~ (2018)
13. Popov LD, "Mitochondrial-derived vesicles : recent insights", J Cell Mol Med, 26, pp.3323~3328 (2022)
14. Heyn J, "Mitochondrial-derived vesicles-link to extracellular vesicles and implications in cardiovascular disease", Int J Mol Sci, 24, pp.2637~ (2023)
15. Bartolini Gritti B, "Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis", Hamostaseologie, 36, pp.89~96 (2016)
16. Dixson AC, "Context-specific regulation of extracellular vesicle biogenesis and cargo selection", Nat Rev Mol Cell Biol, 24, pp.454~476 (2023)
17. Chuo ST, "Imaging extracellular vesicles : current and emerging methods", J Biomed Sci, 25, pp.91~ (2018)
18. Verweij FJ, "The power of imaging to understand extracellular vesicle biology in vivo", Nat Methods, 18, pp.1013~1026 (2021)
19. Boulanger CM, "Extracellular vesicles in coronary artery disease", Nat Rev Cardiol, 14, pp.259~272 (2017)
20. Jansen F, "Extracellular vesicles in cardiovascular disease : potential applications in diagnosis, prognosis, and epidemiology", Circ Res, 120, pp.1649~1657 (2017)
21. Skliar M, "Membrane proteins significantly restrict exosome mobility", Biochem Biophys Res Commun, 501, pp.1055~1059 (2018)
22. Iannotta D, "Entry and exit of extracellular vesicles to and from the blood circulation", Nat Nanotechnol, 19, pp.13~20 (2024)
23. Li Y, "EV-origin : Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile", Comput Struct Biotechnol J, 18, pp.2851~2859 (2020)
24. Marchisio M, "Flow cytometry analysis of circulating extracellular vesicle subtypes from fresh peripheral blood samples", Int J Mol Sci, 22, pp.48~ (2020)
25. Dickhout A, "Extracellular vesicles as biomarkers in cardiovascular disease; chances and risks", Front Cardiovasc Med, 5, pp.113~ (2018)
26. Suades R, "Extracellular vesicles as drivers of immunoinflammation in atherothrombosis", Cells, 11, pp.1845~ (2022)
27. Olejarz W, "Extracellular vesicles in atherosclerosis : state of the art", Int J Mol Sci, 25, pp.388~ (2024)
28. Badimon L, "Extracellular vesicles in atherothrombosis : from biomarkers and precision medicine to therapeutic targets", Immunol Rev, 312, pp.6~19 (2022)
29. Davidson SM, "Methods for the identification and characterization of extracellular vesicles in cardiovascular studies : from exosomes to microvesicles", Cardiovasc Res, 119, pp.45~63 (2023)
30. Amabile N, "Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study", Eur Heart J, 35, pp.2972~2979 (2014)
31. Badimon L, "Microvesicles in atherosclerosis and angiogenesis : from bench to bedside and reverse", Front Cardiovasc Med, 4, pp.77~ (2017)
32. Preston RA, "Effects of severe hypertension on endothelial and platelet microparticles", Hypertension, 41, pp.211~217 (2003)
33. Nomura S, "Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus", Clin Appl Thromb Hemost, 10, pp.133~141 (2004)
34. Ferreira AC, "Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles", Circulation, 110, pp.3599~3603 (2004)
35. Contreras-Duarte S, "Small extracellular vesicles from pregnant women with maternal supraphysiological hypercholesterolemia impair endothelial cell function in vitro", Vascul Pharmacol, 150, pp.107174~ (2023)
36. Feng B, "Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus", Atherosclerosis, 208, pp.264~269 (2010)
37. Kurtzman N, "Personalized cytomic assessment of vascular health : Evaluation of the vascular health profile in diabetes mellitus", Cytometry B Clin Cytom, 84, pp.255~266 (2013)
38. Gündüz Z, "Increased endothelial microparticles in obese and overweight children", J Pediatr Endocrinol Metab, 25, pp.1111~1117 (2012)
39. Arteaga RB, "Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome", Am J Cardiol, 98, pp.70~74 (2006)
40. Gordon C, "Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers", Am J Respir Crit Care Med, 184, pp.224~232 (2011)
41. Wang C, "Nicotine exacerbates endothelial dysfunction and drives atherosclerosis via extracellular vesicle-miRNA", Cardiovasc Res, 119, pp.729~742 (2023)
42. Badimon L, "Diet, microparticles and atherothrombosis", Front Biosci(Landmark Ed), 23, pp.432~457 (2018)
43. Boyle LJ, "Impact of reduced daily physical activity on conduit artery flow-mediated dilation and circulating endothelial microparticles", J Appl Physiol, 115, pp.1519~1525 (2013)
44. Miller VM, "Specific cell-derived microvesicles : Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women", Atherosclerosis, 246, pp.21~28 (2016)
45. Lukasik M, "Enhanced platelet-derived microparticle formation is associated with carotid atherosclerosis in convalescent stroke patients", Platelets, 24, pp.63~70 (2013)
46. Bernal-Mizrachi L, "High levels of circulating endothelial microparticles in patients with acute coronary syndromes", Am Heart J, 145, pp.962~970 (2003)
47. Philippova M, "T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis", Eur Heart J, 32, pp.760~771 (2011)
48. Suades R, "High levels of TSP1+", CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis, 2015, pp.114, 1310~1321
49. Chiva-Blanch G, "Liquid biopsy of extracellular microvesicles maps coronary calcification and atherosclerotic plaque in asymptomatic patients with familial hypercholesterolemia", Arterioscler Thromb Vasc Biol, 39, pp.945~955 (2019)
50. Nozaki T, "Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease", J Am Coll Cardiol, 54, pp.601~608 (2009)
51. Sinning JM, "Circulating CD31+", annexin V+ microparticles correlate with cardiovascular outcomes, 2011, pp.32, 2034~2041
52. Sarlon-Bartoli G, "Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis", J Am Coll Cardiol, 62, pp.1436~1441 (2013)
53. Zacharia E, "Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes", J Mol Cell Cardiol, 138, pp.110~114 (2020)
54. Martin-Ventura JL, "Role of extracellular vesicles as potential diagnostic and", or therapeutic biomarkers in chronic cardiovascular diseases, 2022, pp.10, 813885~
55. Heinrich LF, "Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells", Br J Nutr, 113, pp.1704~1711 (2015)
56. Liu ML, "Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns : mechanisms of formation, action, and detoxification", Arterioscler Thromb Vasc Biol, 32, pp.2113~2121 (2012)
57. Perdomo L, "Large extracellular vesicle-associated Rap1 accumulates in atherosclerotic plaques, correlates with vascular risks and is involved in atherosclerosis", Circ Res, 127, pp.747~760 (2020)
58. Jaśkiewicz A, "The many faces of Rap1 GTPase", Int J Mol Sci, 19, pp.2848~ (2018)
59. Bouchareychas L, "High glucose macrophage exosomes enhance atherosclerosis by driving cellular proliferation & hematopoiesis", iScience, 24, pp.102847~ (2021)
60. Yu H, "Diabetes is accompanied by secretion of pro-atherosclerotic exosomes from vascular smooth muscle cells", Cardiovasc Diabetol, 22, pp.112~ (2023)
61. Jansen F, "High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation", Cardiovasc Res, 98, pp.94~106 (2013)
62. Zietzer A, "Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides", Cell Mol Life Sci, 79, pp.48~ (2021)
63. Catalano M, "Inhibiting extracellular vesicles formation and release : a review of EV inhibitors", J Extracell Vesicles, 9, pp.1703244~ (2019)
64. Zhang P, "Serum-derived exosomes from patients with coronary artery disease induce endothelial injury and inflammation in human umbilical vein endothelial cells", Int Heart J, 62, pp.396~406 (2021)
65. Tong X, "Exosome-derived circ_0001785 delays atherogenesis through the ceRNA network mechanism of miR-513a-5p", TGFBR3, 2023, pp.21, 362~
66. Peng M, "Extracellular vesicles carrying proinflammatory factors may spread atherosclerosis to remote locations", Cell Mol Life Sci, 79, pp.430~ (2022)
67. Leroyer AS, "Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques", J Am Coll Cardiol, 49, pp.772~777 (2007)
68. Mayr M, "Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques", Circ Cardiovasc Genet, 2, pp.379~388 (2009)
69. Perrotta I, "Exosomes in human atherosclerosis : an ultrastructural analysis study", Ultrastruct Pathol, 40, pp.101~106 (2016)
70. Rautou PE, "Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration", Circ Res, 108, pp.335~343 (2011)
71. Papahadjopoulos D, "Molecular mechanisms of calcium-induced membrane fusion", J Bioenerg Biomembr, 22, pp.157~179 (1990)
72. Burger KN, "Greasing membrane fusion and fission machineries", Traffic, 1, pp.605~613 (2000)
73. Wen Y, "circRNA-0006896-miR1264-DNMT1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis", Mol Med Rep, 23, pp.311~ (2021)
74. Hosseinkhani B, "Extracellular vesicles work as a functional inflammatory mediator between vascular endothelial cells and immune cells", Front Immunol, 9, pp.1789~ (2018)
75. Brodsky SV, "Endothelium-derived microparticles impair endothelial function in vitro", Am J Physiol Heart Circ Physiol, 286, pp.H1910~ (2004)
76. Jansen F, "Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism", J Cell Mol Med, 19, pp.2202~2214 (2015)
77. Paudel KR, "Microparticles-mediated vascular inflammation and its amelioration by antioxidant activity of baicalin", Antioxidants, 9, pp.890~ (2020)
78. Densmore JC, "Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury", Shock, 26, pp.464~471 (2006)
79. Chatterjee V, "Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis", Cardiovasc Res, 116, pp.1525~1538 (2020)
80. Barry OP, "Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles", J Clin Invest, 99, pp.2118~2127 (1997)
81. Barry OP, "Modulation of monocyte-endothelial cell interactions by platelet microparticles", J Clin Invest, 102, pp.136~144 (1998)
82. Nomura S, "High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells", Atherosclerosis, 158, pp.277~287 (2001)
83. Mause SF, "Platelet microparticles : a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium", Arterioscler Thromb Vasc Biol, 25, pp.1512~1518 (2005)
84. Kuravi SJ, "Ability of platelet-derived extracellular vesicles to promote neutrophil-endothelial cell interactions", Inflammation, 42, pp.290~305 (2019)
85. Binder CJ, "Innate sensing of oxidation-specific epitopes in health and disease", Nat Rev Immunol, 16, pp.485~497 (2016)
86. Marchini JF, "Oxidized low-density lipoprotein induces macrophage production of prothrombotic microparticles", J Am Heart Assoc, 9, pp.e015878~ (2020)
87. Liang W, "MiR-199a-5p-containing macrophage-derived extracellular vesicles inhibit SMARCA4 and alleviate atherosclerosis by reducing endothelial cell pyroptosis", Cell Biol Toxicol, 39, pp.591~605 (2023)
88. Keyel PA, "Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formation", J Immunol, 189, pp.4621~4629 (2012)
89. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
90. Tang N, "Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells", FASEB J, 30, pp.3097~3106 (2016)
91. Aharon A, "Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells", Thromb Haemost, 100, pp.878~885 (2008)
92. Gao W, "Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway", J Cell Mol Med, 20, pp.2318~2327 (2016)
93. Gomez I, "Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium", Nat Commun, 11, pp.214~ (2020)
94. Puhm F, "Mitochondria are a subset of extracellular vesicles released by activated monocytes and induce type I IFN and TNF responses in endothelial cells", Circ Res, 125, pp.43~52 (2019)
95. Liu Q, "The role of mitochondria in NLRP3 inflammasome activation", Mol Immunol, 103, pp.115~124 (2018)
96. Wang JG, "Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner", Blood, 118, pp.2366~2374 (2011)
97. Hoyer FF, "Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice", J Cell Mol Med, 16, pp.2777~2788 (2012)
98. Tsiantoulas D, "Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies", J Lipid Res, 56, pp.440~448 (2015)
99. Huber J, "Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions", Arterioscler Thromb Vasc Biol, 22, pp.101~107 (2002)
100. Obermayer G, "Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis", Blood, 137, pp.1406~1415 (2021)
101. Porsch F, "Humoral immunity in atherosclerosis and myocardial infarction : from B cells to antibodies", Cardiovasc Res, 117, pp.2544~2562 (2021)
102. Garza AP, "Initial and ongoing tobacco smoking elicits vascular damage and distinct inflammatory response linked to neurodegeneration", Brain Behav Immun Health, 28, pp.100597~ (2023)
103. Gao Y, "Extracellular vesicles derived from PM2. 5-exposed alveolar epithelial cells mediate endothelial adhesion and atherosclerosis in ApoE-", -mice, 2022, pp.36, e22161~
104. Tuleta I, "Hypoxia-induced endothelial dysfunction in apolipoprotein E-deficient mice; effects of infliximab and L-glutathione", Atherosclerosis, 236, pp.400~410 (2014)
105. Devaraj S, "C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo : further evidence of endothelial dysfunction", Clin Chem, 57, pp.1757~1761 (2011)
106. Raju S, "Directional endothelial communication by polarized extracellular vesicle release", Circ Res, 134, pp.269~289 (2024)
107. Njock MS, "Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs", Blood, 125, pp.3202~3212 (2015)
108. Huang C, "Exosomal MALAT1 derived from oxidized low-density lipoprotein-treated endothelial cells promotes M2 macrophage polarization", Mol Med Rep, 18, pp.509~515 (2018)
109. He S, "Endothelial extracellular vesicles modulate the macrophage phenotype : Potential implications in atherosclerosis", Scand J Immunol, 87, pp.e12648~ (2018)
110. Nakajima H, "Flow pattern-dependent endothelial cell responses through transcriptional regulation", Cell Cycle, 16, pp.1893~1901 (2017)
111. Krüger-Genge A, "Vascular endothelial cell biology : an update", Int J Mol Sci, 20, pp.4411~ (2019)
112. Li YS, "Molecular basis of the effects of shear stress on vascular endothelial cells", J Biomech, 38, pp.1949~1971 (2005)
113. Liang J, "Endothelial cell morphology regulates inflammatory cells through microRNA transferred by extracellular vesicles", Front Bioeng Biotechnol, 8, pp.369~ (2020)
114. Wieland EB, "Macrophage heterogeneity in atherosclerosis : a matter of context", Eur J Immunol, 54, pp.e2350464~ (2024)
115. Zernecke A, "Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis", Cardiovasc Res, 119, pp.1676~1689 (2023)
116. Eligini S, "Macrophage phenotyping in atherosclerosis by proteomics", Int J Mol Sci, 24, pp.2613~ (2023)
117. Ismail N, "Macrophage microvesicles induce macrophage differentiation and miR-223 transfer", Blood, 121, pp.984~995 (2013)
118. Nguyen MA, "Extracellular vesicles secreted by atherogenic macrophages transfer microRNA to inhibit cell migration", Arterioscler Thromb Vasc Biol, 38, pp.49~63 (2018)
119. Głuchowska A, "Unbiased proteomic analysis of extracellular vesicles secreted by senescent human vascular smooth muscle cells reveals their ability to modulate immune cell functions", Geroscience, 44, pp.2863~2884 (2022)
120. Zakharova L, "T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor", J Cell Physiol, 212, pp.174~181 (2007)
121. Ding J, "miR-186-5p dysregulation in serum exosomes from patients with AMI aggravates atherosclerosis via targeting LOX-1", Int J Nanomedicine, 17, pp.6301~6316 (2022)
122. Feng C, "Platelet-derived microparticles promote phagocytosis of oxidized low-density lipoprotein by macrophages, potentially enhancing foam cell formation", Ann Transl Med, 7, pp.477~ (2019)
123. Orozco LD, "Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis", Circ Res, 100, pp.1703~1711 (2007)
124. Pham TT, "Endocytosis of red blood cell extracellular vesicles by macrophages leads to cytoplasmic heme release and prevents foam cell formation in atherosclerosis", J Extracell Vesicles, 12, pp.e12354~ (2023)
125. Crewe C, "Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes", Cell Metab, 33, pp.1853~1868 (2021)
126. Wadey RM, "Inflammatory adipocyte-derived extracellular vesicles promote leukocyte attachment to vascular endothelial cells", Atherosclerosis, 283, pp.19~27 (2019)
127. Xie Z, "Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization", J Am Heart Assoc, 7, pp.e007442~ (2018)
128. Liu Y, "Perivascular adipose-derived exosomes reduce foam cell formation by regulating expression of cholesterol transporters", Front Cardiovasc Med, 8, pp.697510~ (2021)
129. Liu Y, "Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the BMP4-PPARγ-ABCA1", ABCG1 pathways, 2022, pp.143, 106968~
130. Yin L, "The role of peroxisome proliferator-activated receptor gamma and atherosclerosis : post-translational modification and selective modulators", Front Physiol, 13, pp.826811~ (2022)
131. Shankman LS, "KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis", Nat Med, 21, pp.628~637 (2015)
132. Bennett MR, "Vascular smooth muscle cells in atherosclerosis", Circ Res, 118, pp.692~702 (2016)
133. Yap C, "Six shades of vascular smooth muscle cells illuminated by KLF4(Krüppel-like factor 4)", Arterioscler Thromb Vasc Biol, 41, pp.2693~2707 (2021)
134. Wang Y, "Extracellular-vesicle containing miRNA-503-5p released by macrophages contributes to atherosclerosis", Aging(Albany NY), 13, pp.12239~12257 (2021)
135. Ren L, "OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K", AKT, Mol Immunol, pp.2022, 146[DOI]
136. Wang Q, "microRNA-19b-3p-containing extracellular vesicles derived from macrophages promote the development of atherosclerosis by targeting JAZF1", J Cell Mol Med, 26, pp.48~59 (2022)
137. Liu J, "Exosomes promote atherosclerosis progression by regulating circ_100696", miR-503-5p, Int Heart J, pp.2023, 64[DOI]
138. Liu Y, "Exosome-mediated miR-106a-3p derived from ox-LDL exposed macrophages accelerated cell proliferation and repressed cell apoptosis of human vascular smooth muscle cells", Eur Rev Med Pharmacol Sci, 24, pp.7039~7050 (2020)
139. Hu N, "Exosomal long non-coding RNA LIPCAR derived from oxLDL-treated THP-1 cells regulates the proliferation of human umbilical vein endothelial cells and human vascular smooth muscle cells", Biochem Biophys Res Commun, 575, pp.65~72 (2021)
140. Zhu J, "Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p", PTEN-mediated VSMC migration and proliferation, 2019, pp.9, 6901~6919
141. Niu C, "Macrophage foam cell-derived extracellular vesicles promote vascular smooth muscle cell migration and adhesion", J Am Heart Assoc, 5, pp.e004099~ (2016)
142. Sarkar A, "Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1", PLoS One, 4, pp.e7140~ (2009)
143. Zhang Z, "Exosomal LINC01005 derived from oxidized low-density lipoprotein-treated endothelial cells regulates vascular smooth muscle cell phenotypic switch", Biofactors, 46, pp.743~753 (2020)
144. Xiang D, "Different effects of endothelial extracellular vesicles and LPS-induced endothelial extracellular vesicles on vascular smooth muscle cells : role of curcumin and its derivatives", Front Cardiovasc Med, 8, pp.649352~ (2021)
145. Jansen F, "Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6", J Mol Cell Cardiol, 104, pp.43~52 (2017)
146. Lin X, "Endothelial cells can regulate smooth muscle cells in contractile phenotype through the miR-206", ARF6&NCX1, PLoS One, pp.2016, 11[DOI]
147. Hergenreider E, "Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs", Nat Cell Biol, 14, pp.249~256 (2012)
148. Distler JH, "The release of microparticles by apoptotic cells and their effects on macrophages", Apoptosis, 10, pp.731~741 (2005)
149. Huber LC, "The role of membrane lipids in the induction of macrophage apoptosis by microparticles", Apoptosis, 12, pp.363~374 (2007)
150. Lin W, "Endothelial exosomes work as a functional mediator to activate macrophages", Front Immunol, 14, pp.1169471~ (2023)
151. Jinnouchi H, "Calcium deposition within coronary atherosclerotic lesion : implications for plaque stability", Atherosclerosis, 306, pp.85~95 (2020)
152. Bakhshian Nik A, "Extracellular vesicles as mediators of cardiovascular calcification", Front Cardiovasc Med, 4, pp.78~ (2017)
153. Bobryshev YV, "Matrix vesicles in the fibrous cap of atherosclerotic plaque : possible contribution to plaque rupture", J Cell Mol Med, 12, pp.2073~2082 (2008)
154. Kapustin AN, "Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization", Circ Res, 109, pp.e1~ (2011)
155. New SE, "Macrophage-derived matrix vesicles : an alternative novel mechanism for microcalcification in atherosclerotic plaques", Circ Res, 113, pp.72~77 (2013)
156. Golub EE, "Role of matrix vesicles in biomineralization", Biochim Biophys Acta, 1790, pp.1592~1598 (2009)
157. Wuthier RE, "Matrix vesicles : structure, composition, formation and function in calcification", Front Biosci(Landmark Ed), 16, pp.2812~2902 (2011)
158. Kapustin AN, "Vascular smooth muscle cell calcification is mediated by regulated exosome secretion", Circ Res, 116, pp.1312~1323 (2015)
159. Furmanik M, "Reactive oxygen-forming Nox5 links vascular smooth muscle cell phenotypic switching and extracellular vesicle-mediated vascular calcification", Circ Res, 127, pp.911~927 (2020)
160. Petsophonsakul P, "Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells", Cardiovasc Res, 118, pp.2196~2210 (2022)
161. Hodroge A, "Oligogalacturonic acid inhibits vascular calcification by two mechanisms : inhibition of vascular smooth muscle cell osteogenic conversion and interaction with collagen", Arterioscler Thromb Vasc Biol, 37, pp.1391~1401 (2017)
162. Goettsch C, "Sortilin mediates vascular calcification via its recruitment into extracellular vesicles", J Clin Invest, 126, pp.1323~1336 (2016)
163. Jing L, "Role of sortilin and matrix vesicles in Nε-carboxymethyl-lysine-induced diabetic atherosclerotic calcification", Diabetes Metab Syndr Obes, 13, pp.4141~4151 (2020)
164. Reynolds JL, "Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification", J Am Soc Nephrol, 16, pp.2920~2930 (2005)
165. Bakhshian Nik A, "Epidermal growth factor receptor inhibition prevents vascular calcifying extracellular vesicle biogenesis", Am J Physiol Heart Circ Physiol, 324, pp.H553~ (2023)
166. Krohn JB, "Discoidin domain receptor-1 regulates calcific extracellular vesicle release in vascular smooth muscle cell fibrocalcific response via transforming growth factor-β signaling", Arterioscler Thromb Vasc Biol, 36, pp.525~533 (2016)
167. Rogers MA, "Lipoprotein(a)induces vesicular cardiovascular calcification revealed with single-extracellular vesicle analysis", Front Cardiovasc Med, 9, pp.778919~ (2022)
168. Hutcheson JD, "Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques", Nat Mater, 15, pp.335~343 (2016)
169. Reynolds JL, "Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations : a potential mechanism for accelerated vascular calcification in ESRD", J Am Soc Nephrol, 15, pp.2857~2867 (2004)
170. Demer L, "The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification", Circ Res, 108, pp.1482~1493 (2011)
171. Cao J, "Extracellular vesicle miR-32 derived from macrophage promotes arterial calcification in mice with type 2 diabetes via inhibiting VSMC autophagy", J Transl Med, 20, pp.307~ (2022)
172. Chen NX, "Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways", Kidney Int, 93, pp.343~354 (2018)
173. Chen NX, "Regulation of reactive oxygen species in the pathogenesis of matrix vesicles induced calcification of recipient vascular smooth muscle cells", Vasc Med, 26, pp.585~594 (2021)
174. Yaker L, "Extracellular vesicles from LPS-treated macrophages aggravate smooth muscle cell calcification by propagating inflammation and oxidative stress", Front Cell Dev Biol, 10, pp.823450~ (2022)
175. Buendía P, "Endothelial microparticles mediate inflammation-induced vascular calcification", FASEB J, 29, pp.173~181 (2015)
176. Liu J, "MicroRNA-32 promotes calcification in vascular smooth muscle cells : Implications as a novel marker for coronary artery calcification", PLoS One, 12, pp.e0174138~ (2017)
177. van der Vorst EP, "A disintegrin and metalloproteases(ADAMs)in cardiovascular, metabolic and inflammatory diseases : aspects for theranostic approaches", Thromb Haemost, 118, pp.1167~1175 (2018)
178. Rizza S, "A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis", Atherosclerosis, 239, pp.459~464 (2015)
179. Schulz B, "ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin", Circ Res, 102, pp.1192~1201 (2008)
180. van der Vorst EP, "Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis", Am J Pathol, 185, pp.1145~1155 (2015)
181. Heo SH, "Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease : involvement of matrix metalloproteinases 2 and 9", J Clin Neurol, 7, pp.69~76 (2011)
182. Zhao X, "Gene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis", Sci Rep, 5, pp.17939~ (2015)
183. Wang Y, "Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development", Atherosclerosis, 289, pp.64~72 (2019)
184. Hanania R, "Classically activated macrophages use stable microtubules for matrix metalloproteinase-9(MMP-9)secretion", J Biol Chem, 287, pp.8468~8483 (2012)
185. Stephens DC, "Spatiotemporal organization and protein dynamics involved in regulated exocytosis of MMP-9 in breast cancer cells", J Gen Physiol, 151, pp.1386~1403 (2019)
186. West ZE, "The trans-SNARE complex VAMP4", Stx6, Vti1b is a key regulator of Golgi to late endosome MT1-MMP transport in macrophages, pp.Traffic, 2021[DOI]
187. Arduise C, "Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor", J Immunol, 181, pp.7002~7013 (2008)
188. Sommer A, "Phosphatidylserine exposure is required for ADAM17 sheddase function", Nat Commun, 7, pp.11523~ (2016)
189. Martínez de Lizarrondo S, "Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo", Arterioscler Thromb Vasc Biol, 32, pp.1477~1487 (2012)
190. Lozito TP, "Endothelial cell microparticles act as centers of matrix metalloproteinsase-2(MMP-2)activation and vascular matrix remodeling", J Cell Physiol, 227, pp.534~549 (2012)
191. Taraboletti G, "Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells", Am J Pathol, 160, pp.673~680 (2002)
192. Gasser O, "Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils", Exp Cell Res, 285, pp.243~257 (2003)
193. Li CJ, "Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke", Am J Pathol, 182, pp.1552~1562 (2013)
194. Lee HD, "Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes", FASEB J, 26, pp.3084~3095 (2012)
195. Folkesson M, "Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms", Thromb Haemost, 114, pp.1165~1174 (2015)
196. Groth E, "Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes", Biochim Biophys Acta, 1863, pp.2795~2808 (2016)
197. Genschmer KR, "Activated PMN exosomes : pathogenic entities causing matrix destruction and disease in the lung", Cell, 176, pp.113~126 (2019)
198. Canault M, "Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme", ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1, 2007, pp.171, 1713~1723
199. Libby P, "Reassessing the mechanisms of acute coronary syndromes", Circ Res, 124, pp.150~160 (2019)
200. Oggero S, "Extracellular vesicles from monocyte", platelet aggregates modulate human atherosclerotic plaque reactivity, 2021, pp.10, 12084~
201. Morel O, "Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction : role of endothelial damage and leukocyte activation", Atherosclerosis, 204, pp.636~641 (2009)
202. Lacroix R, "Activation of plasminogen into plasmin at the surface of endothelial microparticles : a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro", Blood, 110, pp.2432~2439 (2007)
203. Lacroix R, "Leukocyte-and endothelial-derived microparticles : a circulating source for fibrinolysis", Haematologica, 97, pp.1864~1872 (2012)
204. Srikanthan S, "Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions", J Thromb Haemost, 12, pp.1906~1917 (2014)
205. Suades R, "Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques", Thromb Haemost, 108, pp.1208~1219 (2012)
206. Zubairova LD, "Circulating microparticles alter formation, structure, and properties of fibrin clots", Sci Rep, 5, pp.17611~ (2015)
207. Diehl P, "Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability", Thromb Haemost, 119, pp.1295~1310 (2019)
208. Christersson C, "Evaluation of microparticles in whole blood by multicolour flow cytometry assay", Scand J Clin Lab Invest, 73, pp.229~239 (2013)
209. Müller I, "Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets", FASEB J, 17, pp.476~478 (2003)
210. Ettelaie C, "Enhanced binding of tissue factor-microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro", Thromb Haemost, 109, pp.61~71 (2013)
211. Oehmcke S, "Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles", Cell Microbiol, 14, pp.107~119 (2012)
212. Shustova ON, "Differential procoagulant activity of microparticles derived from monocytes, granulocytes, platelets and endothelial cells : impact of active tissue factor", Blood Coagul Fibrinolysis, 28, pp.373~382 (2017)
213. Sinauridze EI, "Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets", Thromb Haemost, 97, pp.425~434 (2007)
214. Aleman MM, "Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability", J Thromb Haemost, 9, pp.2251~2261 (2011)
215. Van Der Meijden PE, "Platelet-and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa", J Thromb Haemost, 10, pp.1355~1362 (2012)
216. Khaspekova SG, "Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets", Biochemistry(Mosc), 81, pp.114~121 (2016)
217. Tripisciano C, "Different potential of extracellular vesicles to support thrombin generation : contributions of phosphatidylserine, tissue factor, and cellular origin", Sci Rep, 7, pp.6522~ (2017)
218. Tripisciano C, "Extracellular vesicles derived from platelets, red blood cells, and monocyte-like cells differ regarding their ability to induce factor XII-dependent thrombin generation", Front Cell Dev Biol, 8, pp.298~ (2020)
219. Falati S, "Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin", J Exp Med, 197, pp.1585~1598 (2003)
220. Del Conde I, "Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation", Blood, 106, pp.1604~1611 (2005)
221. Rothmeier AS, "Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells", J Thromb Haemost, 17, pp.627~634 (2019)
222. Das K, "Factor VIIa induces extracellular vesicles from the endothelium : a potential mechanism for its hemostatic effect", Blood, 137, pp.3428~3442 (2021)
223. Das K, "Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase", J Thromb Haemost, 21, pp.3414~3431 (2023)
224. Collier ME, "Investigation of the filamin A-dependent mechanisms of tissue factor incorporation into microvesicles", Thromb Haemost, 117, pp.2034~2044 (2017)
225. Wei H, "Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets", Sci Rep, 8, pp.9987~ (2018)
226. Collier ME, "Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles", Thromb Haemost, 111, pp.647~655 (2014)
227. Rothmeier AS, "Tissue factor prothrombotic activity is regulated by integrin-arf6 trafficking", Arterioscler Thromb Vasc Biol, 37, pp.1323~1331 (2017)
228. Sabatier F, "Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity", Blood, 99, pp.3962~3970 (2002)
229. Banfi C, "Proteome of endothelial cell-derived procoagulant microparticles", Proteomics, 5, pp.4443~4455 (2005)
230. Holnthoner W, "Endothelial cell-derived extracellular vesicles size-dependently exert procoagulant activity detected by thromboelastometry", Sci Rep, 7, pp.3707~ (2017)
231. Stojkovic S, "IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets", Thromb Haemost, 117, pp.1379~1390 (2017)
232. Scholz T, "Transfer of tissue factor from platelets to monocytes : role of platelet-derived microvesicles and CD62P", Thromb Haemost, 88, pp.1033~1038 (2002)
233. Lösche W, "Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils", Platelets, 15, pp.109~115 (2004)
234. Collier ME, "Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity", Thromb Haemost, 110, pp.966~976 (2013)
235. Mallat Z, "Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques : a role for apoptosis in plaque thrombogenicity", Circulation, 99, pp.348~353 (1999)
236. Pitanga TN, "Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells", BMC Cell Biol, 15, pp.21~ (2014)
237. Pan Y, "Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor", J Immunol, 192, pp.437~446 (2014)
238. Li P, "Endothelial cell-released extracellular vesicles trigger pyroptosis and vascular inflammation to induce atherosclerosis through the delivery of HIF1A-AS2", FASEB J, 37, pp.e22942~ (2023)
239. Cheng X, "M2 macrophage-derived exosomes inhibit apoptosis of HUVEC cell through regulating miR-221-3p expression", BioMed Res Int, 2022, pp.1609244~ (2022)
240. Merten M, "Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb", IIIa-dependent mechanism, 1999, pp.99, 2577~2582
241. Suades R, "Platelet-released extracellular vesicles : the effects of thrombin activation", Cell Mol Life Sci, 79, pp.190~ (2022)

관련 논문AI추천